Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
ELOX Eloxx Pharmaceuticals, Inc. daily Stock Chart
ELOX [NASD]
Eloxx Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.34 Insider Own0.10% Shs Outstand34.02M Perf Week-15.08%
Market Cap72.80M Forward P/E- EPS next Y-0.99 Insider Trans- Shs Float28.50M Perf Month-28.67%
Income-50.90M PEG- EPS next Q-0.30 Inst Own46.50% Short Float4.80% Perf Quarter-70.52%
Sales- P/S- EPS this Y8.10% Inst Trans-1.09% Short Ratio7.76 Perf Half Y-51.03%
Book/sh0.90 P/B2.38 EPS next Y6.60% ROA-77.40% Target Price11.60 Perf Year-81.20%
Cash/sh1.65 P/C1.29 EPS next 5Y- ROE-118.90% 52W Range2.01 - 13.46 Perf YTD-70.92%
Dividend- P/FCF- EPS past 5Y44.90% ROI- 52W High-84.10% Beta1.84
Dividend %- Quick Ratio4.90 Sales past 5Y- Gross Margin- 52W Low6.47% ATR0.47
Employees29 Current Ratio4.90 Sales Q/Q- Oper. Margin- RSI (14)39.72 Volatility17.95% 19.30%
OptionableYes Debt/Eq0.41 EPS Q/Q27.00% Profit Margin- Rel Volume0.36 Prev Close2.34
ShortableYes LT Debt/Eq0.29 EarningsMar 13 AMC Payout- Avg Volume176.47K Price2.14
Recom1.60 SMA20-24.46% SMA50-40.59% SMA200-62.71% Volume62,680 Change-8.55%
Sep-06-19Initiated Janney Buy $14
Dec-24-18Initiated H.C. Wainwright Neutral $10
Jul-03-18Initiated Citigroup Buy
Mar-25-20 09:00AM  Eloxx Pharmaceuticals Provides Update on the Impact of Novel Coronavirus (COVID-19) on Phase 2 Clinical Trials in Cystic Fibrosis GlobeNewswire -16.00%
Mar-11-20 05:32PM  Edited Transcript of ELOX earnings conference call or presentation 5-Mar-20 9:30pm GMT Thomson Reuters StreetEvents -9.43%
Mar-10-20 01:45PM  3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner TipRanks
Mar-05-20 04:00PM  Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -9.92%
02:30PM  Eloxx Pharmaceuticals, Inc to Host Earnings Call ACCESSWIRE
Feb-26-20 04:00PM  Eloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating Resources GlobeNewswire
Jan-14-20 02:30PM  Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase GlobeNewswire -30.34%
Dec-27-19 06:38AM  Will Eloxx Continue to Surge Higher? Zacks
Dec-24-19 07:45AM  Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St. +8.15%
Dec-22-19 06:41PM  Hedge Funds Have Never Been This Bullish On Eloxx Pharmaceuticals, Inc. (ELOX) Insider Monkey
Dec-18-19 07:00AM  Eloxx Pharmaceuticals to Present at the Biotech Showcase 2020 on January 14, 2020 GlobeNewswire
Dec-11-19 05:09PM  Edited Transcript of ELOX earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-06-19 07:43AM  Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue? Zacks -10.47%
Nov-19-19 07:00AM  Eloxx Pharmaceuticals to Present at the Evercore ISI 2nd Annual HealthCONx on December 4th, 2019 GlobeNewswire
Nov-18-19 07:00AM  Eloxx Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference on December 3rd, 2019 GlobeNewswire
Nov-07-19 10:00AM  Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019 GlobeNewswire -7.20%
Nov-05-19 04:01PM  Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -6.89%
Oct-31-19 12:15PM  Eloxx Pharmaceuticals Presents Positive Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC) GlobeNewswire +80.18%
Oct-23-19 12:18PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -6.08%
Oct-10-19 08:41AM  Eloxx Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Business Update on November 5, 2019 GlobeNewswire
Sep-23-19 07:30AM  Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Funding and Support for ELX-02 U.S. Phase 2 Clinical Trial GlobeNewswire -9.74%
Sep-16-19 07:30AM  Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare  Conference on October 3rd, 2019 GlobeNewswire
Sep-13-19 07:48PM  Edited Transcript of ELOX earnings conference call or presentation 7-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Sep-10-19 07:30AM  Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019 GlobeNewswire
Aug-26-19 09:30AM  Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019 GlobeNewswire +11.52%
Aug-13-19 10:01AM  Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 GlobeNewswire
Aug-08-19 12:51PM  Eloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call Transcript Motley Fool +5.44%
Aug-07-19 07:30AM  Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -9.40%
Aug-05-19 08:00AM  Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX-02 in Cystinosis GlobeNewswire -8.40%
Jul-31-19 12:12PM  Eloxx Pharmaceuticals Announces Open Investigational New Drug Application (IND) for a Phase 2 Clinical Trial of ELX-02 in Cystic Fibrosis Patients with the G542X Mutation in the US and Protocol Endorsement from the Cystic Fibrosis Foundation (CFF) GlobeNewswire
Jul-17-19 07:30AM  Eloxx Pharmaceuticals to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8th, 2019 GlobeNewswire
Jun-24-19 04:01PM  Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Jun-20-19 08:36AM  Eloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Stock GlobeNewswire
07:25AM  The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge Benzinga
Jun-19-19 04:01PM  Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire -6.50%
Jun-10-19 08:00AM  Eloxx Pharmaceuticals Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome Canada GlobeNewswire
Jun-06-19 04:27PM  Why Advanced Micro Devices, Ciena, and Eloxx Pharmaceuticals Jumped Today Motley Fool +10.42%
01:34PM  Eloxx Pharma Says ELX-02 Data Showed Increases In Key Metric Benzinga
12:30PM  Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS) GlobeNewswire
May-27-19 11:10AM  Investors Who Bought Eloxx Pharmaceuticals (NASDAQ:ELOX) Shares A Year Ago Are Now Down 36% Simply Wall St.
May-21-19 12:50PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors ACCESSWIRE
May-19-19 09:29PM  Edited Transcript of ELOX earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-09-19 02:50PM  Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2019 Earnings Call Transcript Motley Fool +7.63%
07:00AM  Eloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire
May-02-19 10:30AM  Eloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology ARVO 2019 Annual Meeting GlobeNewswire
Apr-22-19 09:37AM  Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019 GlobeNewswire
Apr-15-19 01:15PM  Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019 GlobeNewswire
Apr-11-19 02:45PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Eloxx Pharmaceuticals, Inc. ACCESSWIRE
12:07PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-27-19 09:00AM  Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference GlobeNewswire
Mar-26-19 12:11PM  Proteostasis Plunges on Weak Data From Cystic Fibrosis Study Zacks
Mar-20-19 12:19PM  Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019 GlobeNewswire -7.80%
Mar-12-19 11:35PM  Edited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMT Thomson Reuters StreetEvents
Mar-08-19 11:39AM  Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM  Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
Mar-05-19 09:08AM  Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 GlobeNewswire
Feb-26-19 04:02PM  Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis GlobeNewswire
Feb-20-19 04:00PM  Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019 GlobeNewswire
Feb-19-19 07:00AM  Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 GlobeNewswire
Feb-14-19 08:40AM  Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019 GlobeNewswire +5.48%
Feb-13-19 11:12AM  Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019 GlobeNewswire
Feb-04-19 07:00AM  Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019 GlobeNewswire
Jan-03-19 01:08PM  Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE in San Francisco on Wednesday, January 9, 2019 GlobeNewswire
Dec-20-18 02:54PM  Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful? Simply Wall St. +8.96%
Dec-19-18 05:37AM  Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't American City Business Journals
Dec-17-18 08:39PM  Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-20-18 07:00AM  Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018 GlobeNewswire
Nov-19-18 07:00AM  Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018 GlobeNewswire
Nov-08-18 07:00AM  Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire +18.73%
Oct-18-18 11:49AM  Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC) GlobeNewswire
Oct-16-18 06:16PM  Eloxx Pharmaceuticals To Report Third Quarter 2018 Financial Results and Provide Business Update On November 8, 2018 GlobeNewswire
Sep-24-18 07:00AM  Eloxx Pharmaceuticals To Present at the 8th Orphan Drugs & Rare Diseases Congress, the Oppenheimer Fall Summit, and the 2018 Cantor Global Healthcare Conference GlobeNewswire
Aug-07-18 04:01PM  Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
Jul-18-18 07:30AM  Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-17-18 07:30AM  Eloxx Pharmaceuticals To Report Second Quarter 2018 Financial Results On August 7, 2018 and Host Webcast and Conference Call GlobeNewswire
Jun-25-18 04:20PM  Eloxx Expands Leadership Team with Two Global Pharmaceutical Executives to Accelerate Growth GlobeNewswire
Jun-18-18 07:30AM  Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate Secretary GlobeNewswire -10.40%
Jun-11-18 07:30AM  Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update CNW Group +9.17%
Jun-08-18 11:00AM  Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 41st European Cystic Fibrosis Conference (ECFS) GlobeNewswire
May-10-18 04:01PM  Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
May-01-18 01:27PM  Eloxx Pharmaceuticals To Report First Quarter 2018 Financial Results On May 10, 2018 and Host Webcast and Conference Call GlobeNewswire +8.07%
Apr-30-18 04:01PM  Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters Option to Purchase Additional Shares GlobeNewswire +7.63%
Apr-27-18 12:41PM  Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis GlobeNewswire
Apr-25-18 06:22PM  Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock GlobeNewswire
Apr-24-18 04:01PM  Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Apr-18-18 11:30AM  Eloxx Pharmaceuticals Announces that Two Abstracts for ELX-02 Have Been Accepted for Presentation at the 41st European Cystic Fibrosis Conference GlobeNewswire
Mar-19-18 07:00AM  Eloxx Pharmaceuticals Reports Full Year 2017 Financial and Operating Results and Provides Business Update GlobeNewswire
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops novel ribonucleic acid for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which has completed Phase 1 clinical trial that focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.
open in yahoo | open in reuters | open in google